Zakharova lampoons BBC Russian in trying to dig up dirt on RT situationRussian Politics & Diplomacy October 21, 17:55
Russian Black Sea Fleet to get two Varshavyanka subs Oct 25 and Nov 25 — manufacturerMilitary & Defense October 21, 17:39
Photos of the week: Russian Patriarch’s royal corgi, Putin in Berlin and Trump's familySociety & Culture October 21, 17:32
Russia extends Aleppo humanitarian pauseWorld October 21, 17:27
Russian lawmakers lash out at Belgium for resusal to aknowledge Hassadjek attackRussian Politics & Diplomacy October 21, 17:18
Upgraded Night Hunter to be armed with extended range anti-tank missilesMilitary & Defense October 21, 16:56
Italian helicopters to explore Arctic for Rosneft — manufacturerBusiness & Economy October 21, 16:52
Lawmaker: EU summit proves that Europe has got tired of anti-Russian sanctionsRussian Politics & Diplomacy October 21, 16:38
Russian lawmaker says sanction opponents in EU choke off terror support in SyriaRussian Politics & Diplomacy October 21, 16:10
The deadly virus has already killed more than 5,000 people, mainly in Guinea, Liberia and Sierra-Leone, he said.
Most Ebola cases (6,535) were reported in Liberia, Aylward said adding that the WHO was "cautiously optimistic" that the rate of new cases in this West African country was slowing down.
"We are seeing slowing rate of new cases, very definitely," he said.
Aylward also said that Ebola cases were also reported in Mali, Spain and the United States, while Nigeria and Senegal were declared Ebola-free.
The Ebola virus disease, previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate. No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.